Delivery Order SPE2DB24D2205-SPE2DB24FEAJN
Award Date
9/24/24
Potential Completion Date
9/25/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,125.53, is for the delivery of OLOPATADINE HCL 0.1% eye drops, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Olopatadine HCL 0.1% eye drops, a pharmaceutical product, with a ceiling value of $1,167.76 and a period of performance ending on May 5, 2023. The contract is a firm fixed-price delivery order and was not set aside for any specific business category. AmerisourceBergen Drug Corp holds...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,978.46, is for the supply of Olopatadine HCl 0.1% eye drops, a pharmaceutical product used for the treatment of eye conditions. The contract has an ultimate completion date of April 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Olopatadine Hydrochloride 0.1% Eye Drops, 5 milliliter, and has a ceiling value of $1,701.55. The contract is not set aside and was awarded on May 12, 2025, with a final completion date of May 13, 2025. Amerisourcebergen Drug Corp is a for-profit organization that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Olopatadine Hydrochloride 0.1% eye drops. The $2,112.82 firm-fixed-price contract has a performance period through May 2025 and is not set aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,308.39, is for the delivery of OLOPATADINE HCL 0.1% eye drops in 5ml quantities. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Olopatadine HCl 0.1% eye drops in 5 ml vials, with a total ceiling value of $1,696.92 and a completion date of January 27, 2025. The contract is a firm fixed-price Delivery Order and does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Olopatadine HCl 0.1% eye drops in 5 ml containers, with a total ceiling value of $1,005.36. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of OLOPATADINE HCL 0.1% eye drops, a pharmaceutical product, with a ceiling value of $2,987.69 and a completion date of January 14, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, that serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,310.09, is for the delivery of Olopatadine HCl 0.1% eye drops in 5ml vials. The contract is a delivery order type with a firm fixed price pricing structure, and the ultimate completion date is December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...